Sonova Holding AG/€SOON
1D1W1MYTD1Y5YMAX
Capital at risk
About Sonova Holding AG
Sonova Holding AG is a Swiss company operating in the healthcare industry, specifically focusing on the development, manufacturing, and distribution of hearing care solutions. Its product portfolio includes hearing aids, cochlear implants, wireless communication devices, and professional audiological care services. Founded in 1947, Sonova is headquartered in Stäfa, Switzerland, and serves a global market with its products available in over 100 countries. The company distinguishes itself through continuous innovation in audiological technology and an integrated approach to hearing healthcare, providing both advanced products and comprehensive support services. Sonova’s strategic positioning is enhanced by its focus on research and development, as well as a robust distribution network that includes a mix of retail and wholesale channels.
- Ticker
- €SOON
- Sector
- Health
- Primary listing
- XGAT
- Employees
- 18,580
- Headquarters
- Stäfa, Switzerland
- Website
- www.sonova.com
SOON Metrics
BasicAdvanced
€14B
31.60
€7.64
1.07
€5.10
2.11%
Price and volume
Market cap
€14B
Beta
1.07
52-week high
€263.20
52-week low
€179.35
Average daily volume
136K
Dividend rate
€5.10
Financial strength
Current ratio
1.753
Quick ratio
1.159
Long term debt to equity
0.579
Total debt to equity
0.649
Dividend payout ratio (TTM)
60.92%
Interest coverage (TTM)
24.56%
Profitability
EBITDA (TTM)
890.357
Gross margin (TTM)
73.72%
Net profit margin (TTM)
11.94%
Operating margin (TTM)
19.55%
Effective tax rate (TTM)
14.91%
Revenue per employee (TTM)
€201,030
Management effectiveness
Return on assets (TTM)
7.63%
Return on equity (TTM)
20.52%
Valuation
Price to earnings (TTM)
31.603
Price to revenue (TTM)
3.772
Price to book
5.19
Price to tangible book (TTM)
183.69
Price to free cash flow (TTM)
22.487
Free cash flow yield (TTM)
4.45%
Free cash flow per share (TTM)
10.742
Dividend yield (TTM)
2.11%
Forward dividend yield
2.11%
Growth
Revenue change (TTM)
-0.19%
Earnings per share change (TTM)
-20.10%
3-year revenue growth (CAGR)
-1.20%
10-year revenue growth (CAGR)
5.70%
3-year earnings per share growth (CAGR)
-12.33%
10-year earnings per share growth (CAGR)
3.54%
3-year dividend per share growth (CAGR)
0.72%
10-year dividend per share growth (CAGR)
8.39%
Bulls say / Bears say
Sonova delivered a robust FY 2025/26 performance, with group sales up 5.9% in local currencies to CHF 3,605.9 million and normalized EBITA rising 17.3% to CHF 811.2 million, driving the EBITA margin to 22.5% on strong operating leverage and market-share gains ([Sonova], [turn2search5]).
For FY 2026/27, Sonova forecasts sales growth of 5–8% and core EBIT expansion of 7–10%, underpinned by a new AI-driven platform launch in H2 2026 to sustain its leadership in premium hearing solutions ([Reuters], [turn1view0]).
The partnership with the Singapore Economic Development Board to establish an Innovation Center for Affordable Hearing Solutions in Singapore bolsters Sonova’s R&D and manufacturing footprint in the high-growth Asia-Pacific market, supporting its medium-term growth ambitions ([EDB], [turn4search0]).
Cochlear Implants segment continues to underperform, with sales down 11.1% in local currencies and normalized EBITA margin plunging to 6.8%, as the business grapples with China’s volume-based procurement and intensified competitor launches ([Sonova], [turn7view0]).
Pronounced foreign-exchange headwinds are set to trim reported growth, with FX expected to shave off 1–2 percentage points of sales and 3–4 points of core EBIT in FY 2026/27, adding volatility to reported Swiss-franc results ([Sonova], [turn7view0]).
Shortening product and platform cycles amid escalating competition demand ever-higher R&D investment, risking margin compression if Sonova cannot refresh its portfolio as frequently as peers advancing AI integration ([Reuters], [turn1view0]).
Data summarised monthly by Lightyear AI. Last updated on 7 Sept 2026.
Upcoming events
No upcoming events
Funds containing SOON
Fund name | Fund size | €SOON weighting |
|---|---|---|
WisdomTree Global Quality Dividend Growth£GGRG | £1.9B | 0.07% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.